GM-CSF alters dendritic cells in autoimmune diseases

References

• Metcalf, D. 2008. Hematopoietic cytokines. Blood. 111: 485–491
   PubMed Web of Science ®Google Scholar
• Greter, M., J. Helft, A. Chow, D. Hashimoto, A. Mortha, J. Agudo-Cantero, M. Bogunovic, et al. 2012. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity. 36: 1031–1046
   PubMed Web of Science ®Google Scholar
• Burgess, A. W., J. Camakaris, and D. Metcalf. 1977. Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J Biol Chem. 252: 1998–2003
   PubMed Web of Science ®Google Scholar
• Metcalf, D. 1986. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood. 67: 257–267
   PubMed Web of Science ®Google Scholar
• Zhan, Y., Y. Xu, and A. M. Lew. 2012. The regulation of the development and function of dendritic cell subsets by GM-CSF: more than a hematopoietic growth factor. Mol Immunol. 52: 30–37
   PubMed Web of Science ®Google Scholar
• Campbell, I. K., A. van Nieuwenhuijze, E. Segura, K. O'Donnell, E. Coghill, M. Hommel, S. Gerondakis, et al. 2011. Differentiation of inflammatory dendritic cells is mediated by NF-kappaB1-dependent GM-CSF production in CD4 T cells. J Immunol. 186: 5468–5477
   PubMed Web of Science ®Google Scholar
• Wodnar-Filipowicz, A., C. H. Heusser, and C. Moroni. 1989. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature. 339: 150–152
   PubMed Web of Science ®Google Scholar
• Lenhoff, S., B. Sallerfors, and T. Olofsson. 1998. IL-10 as an autocrine regulator of CSF secretion by monocytes: disparate effects on GM-CSF and G-CSF secretion. Exp Hematol. 26: 299–304
   PubMed Web of Science ®Google Scholar
• Le, P. T., S. Lazorick, L. P. Whichard, Y. C. Yang, S. C. Clark, B. F. Haynes, and K. H. Singer. 1990. Human thymic epithelial cells produce IL-6, granulocyte-monocyte-CSF, and leukemia inhibitory factor. J Immunol. 145: 3310–3315
   PubMed Web of Science ®Google Scholar
• Broudy, V. C., K. Kaushansky, J. M. Harlan, and J. W. Adamson. 1987. Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. J Immunol. 139: 464–468
   PubMed Web of Science ®Google Scholar
• Nimer, S. D., M. J. Gates, H. P. Koeffler, and J. C. Gasson. 1989. Multiple mechanisms control the expression of granulocyte-macrophage colony-stimulating factor by human fibroblasts. J Immunol. 143: 2374–2377
   PubMed Web of Science ®Google Scholar
• Plenz, G., S. Reichenberg, C. Koenig, J. Rauterberg, M. C. Deng, H. A. Baba, and H. Robenek. 1999. Granulocyte-macrophage colony-stimulating factor (GM-CSF) modulates the expression of type VIII collagen mRNA in vascular smooth muscle cells and both are codistributed during atherogenesis. Arterioscler Thromb Vasc Biol. 19: 1658–1668
   PubMed Web of Science ®Google Scholar
• Djoumerska-Alexieva, I., S. Pashova, T. Vassilev, and A. Pashov. 2013. The protective effect of modified intravenous immunoglobulin in LPS sepsis model is associated with an increased IRA B cells response. Autoimmun Rev. 12: 653--656
   PubMed Web of Science ®Google Scholar
• Hansen, G., T. R. Hercus, B. J. McClure, F. C. Stomski, M. Dottore, J. Powell, H. Ramshaw, et al. 2008. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell. 134: 496–507
   PubMed Web of Science ®Google Scholar
• Dhar-Mascareno, M., J. Chen, R. H. Zhang, J. M. Carcamo, and D. W. Golde. 2003. Granulocyte-macrophage colony-stimulating factor signals for increased glucose transport via phosphatidylinositol 3-kinase- and hydrogen peroxide-dependent mechanisms. J Biol Chem. 278: 11107–11114
   PubMed Web of Science ®Google Scholar
• Hayashida, K., T. Kitamura, D. M. Gorman, K. Arai, T. Yokota, and A. Miyajima. 1990. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA. 87: 9655–9659
   PubMed Web of Science ®Google Scholar
• McClure, B. J., T. R. Hercus, B. A. Cambareri, J. M. Woodcock, C. J. Bagley, G. J. Howlett, and A. F. Lopez. 2003. Molecular assembly of the ternary granulocyte-macrophage colony-stimulating factor receptor complex. Blood. 101: 1308–1315
   PubMed Web of Science ®Google Scholar
• Kitamura, T., N. Sato, K. Arai, and A. Miyajima. 1991. Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell. 66: 1165–1174
   PubMed Web of Science ®Google Scholar
• Hamilton, J. A., and G. P. Anderson. 2004. GM-CSF biology. Growth Factors. 22: 225–231
   PubMed Web of Science ®Google Scholar
• van de Laar, L., P. J. Coffer, and A. M. Woltman. 2012. Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy. Blood. 119: 3383–3393
   PubMed Web of Science ®Google Scholar
• Meads, M. B., Z. W. Li, and W. S. Dalton. 2010. A novel TNF receptor-associated factor 6 binding domain mediates NF-kappa B signaling by the common cytokine receptor beta subunit. J Immunol. 185: 1606–1615
   PubMed Web of Science ®Google Scholar
• Sheng, J. R., T. Muthusamy, B. S. Prabhakar, and M. N. Meriggioli. 2011. GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis. J Neuroimmunol. 240–241: 65–73
   PubMed Web of Science ®Google Scholar
• Hamilton, J. A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol. 8: 533–544
   PubMed Web of Science ®Google Scholar
• McQualter, J. L., R. Darwiche, C. Ewing, M. Onuki, T. W. Kay, J. A. Hamilton, H. H. Reid, and C. C. Bernard. 2001. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J Exp Med. 194: 873–882
   PubMed Web of Science ®Google Scholar
• Ponomarev, E. D., L. P. Shriver, K. Maresz, J. Pedras-Vasconcelos, D. Verthelyi, and B. N. Dittel. 2007. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J Immunol. 178: 39–48
   PubMed Web of Science ®Google Scholar
• Carrieri, P. B., V. Provitera, T. De Rosa, G. Tartaglia, F. Gorga, and O. Perrella. 1998. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity. Immunopharmacol Immunotoxicol. 20: 373–382
   PubMed Web of Science ®Google Scholar
• Campbell, I. K., A. Bendele, D. A. Smith, and J. A. Hamilton. 1997. Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice. Ann Rheum Dis. 56: 364–368
   PubMed Web of Science ®Google Scholar
• Campbell, I. K., M. J. Rich, R. J. Bischof, A. R. Dunn, D. Grail, and J. A. Hamilton. 1998. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J Immunol. 161: 3639–3644
   PubMed Web of Science ®Google Scholar
• Cook, A. D., E. L. Braine, I. K. Campbell, M. J. Rich, and J. A. Hamilton. 2001. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. 3: 293–298
   PubMedGoogle Scholar
• Campbell, I. K., M. J. Rich, R. J. Bischof, and J. A. Hamilton. 2000. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol. 68: 144–150
   PubMed Web of Science ®Google Scholar
• Xu, W. D., G. S. Firestein, R. Taetle, K. Kaushansky, and N. J. Zvaifler. 1989. Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest. 83: 876–882
   PubMed Web of Science ®Google Scholar
• Hazenberg, B. P., M. A. Van Leeuwen, M. H. Van Rijswijk, A. C. Stern, and E. Vellenga. 1989. Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis. Blood. 74: 2769–2770
   PubMed Web of Science ®Google Scholar
• Noguchi, M., N. Hiwatashi, Z. X. Liu, and T. Toyota. 2001. Increased secretion of granulocyte-macrophage colony-stimulating factor in mucosal lesions of inflammatory bowel disease. Digestion. 63: 32–36
   PubMed Web of Science ®Google Scholar
• Ina, K., K. Kusugami, T. Hosokawa, A. Imada, T. Shimizu, T. Yamaguchi, M. Ohsuga, et al. 1999. Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease. J Gastroenterol Hepatol. 14: 46–53
   PubMed Web of Science ®Google Scholar
• Gaudreau, S., C. Guindi, M. Menard, G. Besin, G. Dupuis, and A. Amrani. 2007. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells. J Immunol. 179: 3638–3647
   PubMed Web of Science ®Google Scholar
• Enzler, T., S. Gillessen, M. Dougan, J. P. Allison, D. Neuberg, D. A. Oble, M. Mihm, and G. Dranoff. 2007. Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells. Blood. 110: 954–961
   PubMed Web of Science ®Google Scholar
• Krakowski, M., R. Abdelmalik, L. Mocnik, T. Krahl, and N. Sarvetnick. 2002. Granulocyte macrophage-colony stimulating factor (GM-CSF) recruits immune cells to the pancreas and delays STZ-induced diabetes. J Pathol. 196: 103–112
   PubMed Web of Science ®Google Scholar
• Enzler, T., S. Gillessen, J. P. Manis, D. Ferguson, J. Fleming, F. W. Alt, M. Mihm, and G. Dranoff. 2003. Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. J Exp Med. 197: 1213–1219
   PubMed Web of Science ®Google Scholar
• Vasu, C., R. N. Dogan, M. J. Holterman, and B. S. Prabhakar. 2003. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis. J Immunol. 170: 5511–5522
   PubMed Web of Science ®Google Scholar
• Gangi, E., C. Vasu, D. Cheatem, and B. S. Prabhakar. 2005. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J Immunol. 174: 7006–7013
   PubMed Web of Science ®Google Scholar
• Ganesh, B. B., D. M. Cheatem, J. R. Sheng, C. Vasu, and B. S. Prabhakar. 2009. GM-CSF-induced CD11c+CD8a–dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis. Int Immunol. 21: 269–282
   PubMed Web of Science ®Google Scholar
• Mittag, D., A. I. Proietto, T. Loudovaris, S. I. Mannering, D. Vremec, K. Shortman, L. Wu, and L. C. Harrison. 2011. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. J Immunol. 186: 6207–6217
   PubMed Web of Science ®Google Scholar
• Look, M., A. Bandyopadhyay, J. S. Blum, and T. M. Fahmy. 2010. Application of nanotechnologies for improved immune response against infectious diseases in the developing world. Adv Drug Deliv Rev. 62: 378–393
   PubMed Web of Science ®Google Scholar
• Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol. 164: 2978–2986
   PubMed Web of Science ®Google Scholar
• Kurts, C., M. Cannarile, I. Klebba, and T. Brocker. 2001. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J Immunol. 166: 1439–1442
   PubMed Web of Science ®Google Scholar
• Iyoda, T., S. Shimoyama, K. Liu, Y. Omatsu, Y. Akiyama, Y. Maeda, K. Takahara, et al. 2002. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med. 195: 1289–1302
   PubMed Web of Science ®Google Scholar
• Bedoui, S., P. G. Whitney, J. Waithman, L. Eidsmo, L. Wakim, I. Caminschi, R. S. Allan, et al. 2009. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol. 10: 488–495
   PubMed Web of Science ®Google Scholar
• Belz, G. T., C. M. Smith, D. Eichner, K. Shortman, G. Karupiah, F. R. Carbone, and W. R. Heath. 2004. Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses. J Immunol. 172: 1996–2000
   PubMed Web of Science ®Google Scholar
• Edelson, B. T., T. R. Bradstreet, K. Hildner, J. A. Carrero, K. E. Frederick, W. Kc, R. Belizaire, et al. 2011. CD8alpha(+) dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes. Immunity. 35: 236–248
   PubMed Web of Science ®Google Scholar
• Onai, N., A. Obata-Onai, M. A. Schmid, T. Ohteki, D. Jarrossay, and M. G. Manz. 2007. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat Immunol. 8: 1207–1216
   PubMed Web of Science ®Google Scholar
• Lande, R., and M. Gilliet. 2010. Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann NY Acad Sci. 1183: 89–103
   PubMed Web of Science ®Google Scholar
• Villadangos, J. A., and L. Young. 2008. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity. 29: 352–361
   PubMed Web of Science ®Google Scholar
• Merad, M., F. Ginhoux, and M. Collin. 2008. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol. 8: 935–947
   PubMed Web of Science ®Google Scholar
• King, I. L., M. A. Kroenke, and B. M. Segal. 2010. GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization. J Exp Med. 207: 953–961
   PubMed Web of Science ®Google Scholar
• Poulin, L. F., S. Henri, B. de Bovis, E. Devilard, A. Kissenpfennig, and B. Malissen. 2007. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med. 204: 3119–3131
   PubMed Web of Science ®Google Scholar
• Helft, J., B. Manicassamy, P. Guermonprez, D. Hashimoto, A. Silvin, J. Agudo, B. D. Brown, et al. 2012. Cross-presenting CD103+ dendritic cells are protected from influenza virus infection. J Clin Invest. 122: 4037–4047
   PubMed Web of Science ®Google Scholar
• Shklovskaya, E., B. J. O'Sullivan, L. G. Ng, B. Roediger, R. Thomas, W. Weninger, and B. Fazekas de St Groth. 2011. Langerhans cells are precommitted to immune tolerance induction. Proc Natl Acad Sci USA. 108: 18049–18054
   PubMed Web of Science ®Google Scholar
• Serbina, N. V., T. P. Salazar-Mather, C. A. Biron, W. A. Kuziel, and E. G. Pamer. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 19: 59–70
   PubMed Web of Science ®Google Scholar
• Zhan, Y., and L. Wu. 2012. Functional regulation of monocyte-derived dendritic cells by microRNAs. Protein Cell. 3: 497–507
   PubMed Web of Science ®Google Scholar
• Burnham, K., L. Robb, C. L. Scott, M. O'Keeffe, and K. Shortman. 2000. Effect of granulocyte-macrophage colony-stimulating factor on the generation of epidermal Langerhans cells. J Interferon Cytokine Res. 20: 1071–1076
   PubMed Web of Science ®Google Scholar
• Vremec, D., G. J. Lieschke, A. R. Dunn, L. Robb, D. Metcalf, and K. Shortman. 1997. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur J Immunol. 27: 40–44
   Google Scholar
• Egea, L., Y. Hirata, and M. F. Kagnoff. 2010. GM-CSF: a role in immune and inflammatory reactions in the intestine. Expert Rev Gastroenterol Hepatol. 4: 723–731
   PubMed Web of Science ®Google Scholar
• Shortman, K., and S. H. Naik. 2007. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol. 7: 19–30
   PubMed Web of Science ®Google Scholar
• Zhan, Y., E. M. Carrington, A. van Nieuwenhuijze, S. Bedoui, S. Seah, Y. Xu, N. Wang, et al. 2011. GM-CSF increases cross-presentation and CD103 expression by mouse CD8(+) spleen dendritic cells. Eur J Immunol. 41: 2585–2595
   PubMed Web of Science ®Google Scholar
• Zhan, Y., J. Vega-Ramos, E. M. Carrington, J. A. Villadangos, A. M. Lew, and Y. Xu. 2012. The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells. Eur J Immunol. 42: 2889–2900
   PubMed Web of Science ®Google Scholar
• Esashi, E., Y. H. Wang, O. Perng, X. F. Qin, Y. J. Liu, and S. S. Watowich. 2008. The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity. 28: 509–520
   PubMed Web of Science ®Google Scholar
• Xu, Y., Y. Zhan, A. M. Lew, S. H. Naik, and M. H. Kershaw. 2007. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol. 179: 7577–7584
   PubMed Web of Science ®Google Scholar
• Gilliet, M., A. Boonstra, C. Paturel, S. Antonenko, X. L. Xu, G. Trinchieri, A. O'Garra, and Y. J. Liu. 2002. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med. 195: 953–958
   PubMed Web of Science ®Google Scholar
• McLellan, A. D., M. Kapp, A. Eggert, C. Linden, U. Bommhardt, E. B. Brocker, U. Kammerer, and E. Kampgen. 2002. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood. 99: 2084–2093
   PubMed Web of Science ®Google Scholar
• Vremec, D., and K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J Immunol. 159: 565–573
   PubMed Web of Science ®Google Scholar
• Dresch, C., M. Ackermann, B. Vogt, B. de Andrade Pereira, K. Shortman, and C. Fraefel. 2011. Thymic but not splenic CD8(+) DCs can efficiently cross-prime T cells in the absence of licensing factors. Eur J Immunol. 41: 2544–2555
   PubMed Web of Science ®Google Scholar
• Rapin, N., E. Mosekilde, and O. Lund. 2011. Bistability in autoimmune diseases. Autoimmunity. 44: 256–260
   PubMed Web of Science ®Google Scholar
• Schmidt, S. V., A. C. Nino-Castro, and J. L. Schultze. 2012. Regulatory dendritic cells: there is more than just immune activation. Front Immunol. 3: 274
   PubMed Web of Science ®Google Scholar
• Kis-Toth, K., and G. C. Tsokos. 2010. Dendritic cell function in lupus: Independent contributors or victims of aberrant immune regulation. Autoimmunity. 43: 121–130
   PubMed Web of Science ®Google Scholar
• Mayer, C. T., L. Berod, and T. Sparwasser. 2012. Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity. Front Immunol. 3: 183
   PubMed Web of Science ®Google Scholar
• Platt, C. D., J. K. Ma, C. Chalouni, M. Ebersold, H. Bou-Reslan, R. A. Carano, I. Mellman, and L. Delamarre. 2010. Mature dendritic cells use endocytic receptors to capture and present antigens. Proc Natl Acad Sci USA. 107: 4287–4292
   PubMed Web of Science ®Google Scholar
• Volkmann, A., T. Zal, and B. Stockinger. 1997. Antigen-presenting cells in the thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen. J Immunol. 158: 693–706
   PubMed Web of Science ®Google Scholar
• O'Garra, A., and P. Vieira. 2007. T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol. 7: 425–428
   PubMed Web of Science ®Google Scholar
• Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu Rev Immunol. 18: 767–811
   PubMed Web of Science ®Google Scholar
• Land, W. G. 2005. Injury to allografts: innate immune pathways to acute and chronic rejection. Saudi J Kidney Dis Transpl. 16: 520–539
   PubMedGoogle Scholar
• Janikashvili, N., B. Bonnotte, E. Katsanis, and N. Larmonier. 2011. The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance. Clin Dev Immunol. 2011: 430394
   PubMed Web of Science ®Google Scholar
• Conti, L., and S. Gessani. 2008. GM-CSF in the generation of dendritic cells from human blood monocyte precursors: recent advances. Immunobiology. 213: 859–870
   PubMed Web of Science ®Google Scholar
• Torres-Aguilar, H., M. Blank, L. J. Jara, and Y. Shoenfeld. 2010. Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity. Autoimmun Rev. 10: 8–17
   PubMed Web of Science ®Google Scholar
• Lutz, M. B., N. A. Kukutsch, M. Menges, S. Rossner, and G. Schuler. 2000. Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur J Immunol. 30: 1048–1052
   PubMed Web of Science ®Google Scholar
• Menges, M., S. Rossner, C. Voigtlander, H. Schindler, N. A. Kukutsch, C. Bogdan, K. Erb, et al. 2002. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med. 195: 15–21
   PubMed Web of Science ®Google Scholar
• Gross, C. C., H. Jonuleit, and H. Wiendl. 2012. Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis. Eur J Immunol. 42: 569–572
   PubMed Web of Science ®Google Scholar
• Zou, Y. F., X. L. Feng, F. M. Pan, H. Su, J. H. Tao, and D. Q. Ye. 2010. Meta-analysis of TNF-alpha promoter - 238A/G polymorphism and SLE susceptibility. Autoimmunity 43: 264–274
   PubMed Web of Science ®Google Scholar
• Kanauchi, H., F. Furukawa, and S. Imamura. 1989. Evaluation of ATPase-positive Langerhans' cells in skin lesions of lupus erythematosus and experimentally induced inflammations. Arch Dermatol Res. 281: 327–332
   PubMed Web of Science ®Google Scholar
• Crispin, J. C., M. I. Vargas-Rojas, A. Monsivais-Urenda, and J. Alcocer-Varela. 2012. Phenotype and function of dendritic cells of patients with systemic lupus erythematosus. Clin Immunol. 143: 45–50
   PubMed Web of Science ®Google Scholar
• Scheinecker, C., B. Zwolfer, M. Koller, G. Manner, and J. S. Smolen. 2001. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Arthritis Rheum. 44: 856–865
   PubMedGoogle Scholar
• Fransen, J. H., L. B. Hilbrands, J. Ruben, M. Stoffels, G. J. Adema, J. van der Vlag, and J. H. Berden. 2009. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum. 60: 2304–2313
   PubMed Web of Science ®Google Scholar
• Fehr, E. M., S. Spoerl, P. Heyder, M. Herrmann, I. Bekeredjian-Ding, N. Blank, H. M. Lorenz, and M. Schiller. 2012. Apoptotic-cell-derived membrane vesicles induce an alternative maturation of human dendritic cells which is disturbed in SLE. J Autoimmun. 40: 86–95
   PubMed Web of Science ®Google Scholar
• Teh, B. K., J. G. Yeo, L. M. Chern, J. Lu. 2011. C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation. Mol Immunol. 48: 1128–1138
   PubMed Web of Science ®Google Scholar
• Jongbloed, S. L., M. C. Lebre, A. R. Fraser, J. A. Gracie, R. D. Sturrock, P. P. Tak, and I. B. McInnes. 2006. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res Ther. 8: R15
   PubMed Web of Science ®Google Scholar
• Thomas, R., L. S. Davis, and P. E. Lipsky. 1994. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol. 152: 2613–2623
   PubMed Web of Science ®Google Scholar
• MacDonald, K. P., A. R. Pettit, C. Quinn, G. J. Thomas, and R. Thomas. 1999. Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10. J Immunol. 163: 5599–5607
   PubMed Web of Science ®Google Scholar
• Lebre, M. C., and P. P. Tak. 2008. Dendritic cell subsets: their roles in rheumatoid arthritis. Acta Rheumatol Port. 33: 35–45
   PubMed Web of Science ®Google Scholar
• Radstake, T. R., P. L. van Lent, G. J. Pesman, A. B. Blom, F. G. Sweep, J. Ronnelid, G. J. Adema, et al. 2004. High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FcgammaR triggering. Ann Rheum Dis. 63: 696–702
   PubMed Web of Science ®Google Scholar
• Roelofs, M. F., L. A. Joosten, S. Abdollahi-Roodsaz, A. W. van Lieshout, T. Sprong, F. H. van den Hoogen, W. B. van den Berg, and T. R. Radstake. 2005. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum. 52: 2313–2322
   PubMed Web of Science ®Google Scholar
• Tsark, E. C., W. Wang, Y. C. Teng, D. Arkfeld, G. R. Dodge, and S. Kovats. 2002. Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages. J Immunol. 169: 6625–6633
   PubMed Web of Science ®Google Scholar
• Karman, J., H. H. Chu, D. O. Co, C. M. Seroogy, M. Sandor, and Z. Fabry. 2006. Dendritic cells amplify T cell-mediated immune responses in the central nervous system. J Immunol. 177: 7750–7760
   PubMed Web of Science ®Google Scholar
• Sun, Y., I. Peng, K. Senger, K. Hamidzadeh, M. Reichelt, M. Baca, R. Yeh, et al. 2013. Critical role of activation induced cytidine deaminase in experimental autoimmune Encephalomyelitis. Autoimmunity. 46: 157–167
   PubMed Web of Science ®Google Scholar
• Greter, M., F. L. Heppner, M. P. Lemos, B. M. Odermatt, N. Goebels, T. Laufer, R. J. Noelle, and B. Becher. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med. 11: 328–334
   PubMed Web of Science ®Google Scholar
• Karni, A., M. Abraham, A. Monsonego, G. Cai, G. J. Freeman, D. Hafler, S. J. Khoury, and H. L. Weiner. 2006. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J Immunol. 177: 4196–4202
   PubMed Web of Science ®Google Scholar
• Huang, Y. M., B. G. Xiao, V. Ozenci, M. Kouwenhoven, N. Teleshova, S. Fredrikson, and H. Link. 1999. Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines. J Neuroimmunol. 99: 82–90
   PubMed Web of Science ®Google Scholar
• King, I. L., T. L. Dickendesher, and B. M. Segal. 2009. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood. 113: 3190–3197
   PubMed Web of Science ®Google Scholar
• Mausberg, A. K., S. Jander, and G. Reichmann. 2009. Intracerebral granulocyte-macrophage colony-stimulating factor induces functionally competent dendritic cells in the mouse brain. Glia. 57: 1341–1350
   PubMed Web of Science ®Google Scholar
• Hesske, L., C. Vincenzetti, M. Heikenwalder, M. Prinz, W. Reith, A. Fontana, and T. Suter. 2010. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation. Brain. 133: 1637–1654
   PubMed Web of Science ®Google Scholar
• Burmester, G. R., E. Feist, M. A. Sleeman, B. Wang, B. White, and F. Magrini. 2011. Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-alpha, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study. Ann Rheum Dis. 70: 1542–1549
   PubMed Web of Science ®Google Scholar
• Burmester, G. R., M. E. Weinblatt, I. B. McInnes, D. Porter, O. Barbarash, M. Vatutin, I. Szombati, et al. 2012. Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Ann Rheum Dis [Epub ahead of print]
   Google Scholar
• ClinicalTrials.gov. Information provided by MorphoSys AG. http://clinicaltrials.gov/ct2/show/NCT01023256?term=MOR+103&rank=1 (Accessed January 20, 2013)
   Google Scholar
• ClinicalTrials.gov. Information provided by MorphoSys AG. http://clinicaltrials.gov/ct2/show/NCT01517282?term=MOR+103&rank=2 (Accessed January 20, 2013)
   Google Scholar
• ClinicalTrials.gov. Information provided by KaloBios Pharmaceuticals. http://clinicaltrials.gov/ct2/show/NCT00995449?term=KB003&rank=2 (Accessed January 20, 2013)
   Google Scholar
• ClinicalTrials.gov. Information provided by KaloBios Pharmaceuticals. http://clinicaltrials.gov/ct2/show/NCT01603277?term=KB003&rank=1 (Accessed January 20, 2013)
   Google Scholar
• Tazawa, R., B. C. Trapnell, Y. Inoue, T. Arai, T. Takada, Y. Nasuhara, N. Hizawa, et al. 2010. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 181: 1345–1354
   PubMed Web of Science ®Google Scholar